Recognition and treatment of γ-hydroxybutyric acid poisoning;Herkenning en behandeling van hydroxyboterzuurintoxicaties

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 17, 2004, Pages 844-846

  Van Rij, C M ^a   Wilhelm, A J ^a   Van Loenen, A C ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Klinisch Farmacoloog ^*

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID;

ARTIFICIAL VENTILATION; ASPIRATION; CONVALESCENCE; DRUG INTOXICATION; DRUG OVERDOSE; EMERGENCY TREATMENT; HEALTH HAZARD; HUMAN; REVIEW; SUBSTANCE ABUSE;

EMERGENCIES; HUMANS; HYDROXYBUTYRATES; OVERDOSE; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 1942467103     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Tunnicliff G. Sites of action of gamma-hydroxybutyrate (GHB) - a neuroactive drug with abuse potential. J Toxicol Clin Toxicol 1997; 35:581-90.
2. Mason PE, Kerns 2nd WP. Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 2002;9:730-9.
3. Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxy-methamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health Syst Pharm 2002;59:1067-76.
4. Zvosec DL, Smith SW, McCutcheon JR, Spillane J, Hall BJ, Peacock EA. Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med 2001;344:87-94.
5. Li J, Stokes SA, Woeckener A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med 1998;31:729-36.
6. Vree TB, Baars AM, Kleijn E van der. Capaciteits-gelimiteerde eliminatie van 4-hydroxybutyrate, ethanol en vinylbital. Pharm Weekbl 1975;110:1257-62.
7. Ven L van de, Stolk LML. Partydrugs. Farmacologisch riskante recreatie. Pharma Selecta 2003;5:85-8.
8. Geneesmiddel Informatie Centrum van het Wetenschappelijk Instituut Nederlandse Apothekers. Informatorium medicamentorum. Den Haag: Koninklijke Nederlandse Maatschappij ter Bevordering der Pharmacie; 2003. p. 14.
9. Sluijs T. Jaarverslag Ambulant Medisch Team. Amsterdam: Maatschappelijke Geestelijke Gezondheidszorg; 2002.
10. Hornfeldt CS, Lothridge K, Upshaw Downs JC. Forensic science update: gamma-hydroxybutyrate (GHB). Forensic Sci Commun 2002;4:1.
11. Schwartz RH, Milteer R, LeBeau MA. Drug-facilitated sexual assault ('date rape'). South Med J 2000;93:558-61.
12. Teter CJ, Guthrie SK. A comprehensive review of MDMA and GHB: two common club drugs. Pharmacotherapy 2001;21:1486-513.
13. Hutchison TA, Shahan DR, editors. Drugdex system. Greenwood Village: Micromedex; 2003.
14. Caldicott DGE, Kulin M. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug? Ann Emerg Med 2001;37:99-102.
15. Okun MS, Boothby LA, Bartfield RB, Doering PL. GHB: an important pharmacologic and clinical update. J Pharm Pharm Sci 2001;4:167-75.
16. Veer NE van 't, Lameijer W. Gammahydroxyboterzuur. Bepaling in serum. Pharm Weekbl 2001;136:104-5.
17. Alston 2nd WC, Ng K. Rapid colorimetric screening test for gamma hydroxybutyric acid (liquid X) in human urine. Forensic Sci Int 2002;126:114-7.